
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Baclofen for alcohol use disorder
Silvia Minozzi, Rosella Saulle, Susanne Rösner
Cochrane library (2018) Vol. 2018, Iss. 11
Open Access | Times Cited: 66
Silvia Minozzi, Rosella Saulle, Susanne Rösner
Cochrane library (2018) Vol. 2018, Iss. 11
Open Access | Times Cited: 66
Showing 1-25 of 66 citing articles:
Advances in the science and treatment of alcohol use disorder
Katie Witkiewitz, Raye Z. Litten, Lorenzo Leggio
Science Advances (2019) Vol. 5, Iss. 9
Open Access | Times Cited: 441
Katie Witkiewitz, Raye Z. Litten, Lorenzo Leggio
Science Advances (2019) Vol. 5, Iss. 9
Open Access | Times Cited: 441
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Elizabeth M. Burnette, Steven J. Nieto, Erica N. Grodin, et al.
Drugs (2022) Vol. 82, Iss. 3, pp. 251-274
Open Access | Times Cited: 110
Elizabeth M. Burnette, Steven J. Nieto, Erica N. Grodin, et al.
Drugs (2022) Vol. 82, Iss. 3, pp. 251-274
Open Access | Times Cited: 110
Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives
Szu-Yi Liu, I‐Ting Tsai, Yin-Chou Hsu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5170-5170
Open Access | Times Cited: 102
Szu-Yi Liu, I‐Ting Tsai, Yin-Chou Hsu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5170-5170
Open Access | Times Cited: 102
Baclofen therapeutics, toxicity, and withdrawal: A narrative review
Jia W. Romito, Emily R. Turner, John A. Rosener, et al.
SAGE Open Medicine (2021) Vol. 9
Open Access | Times Cited: 94
Jia W. Romito, Emily R. Turner, John A. Rosener, et al.
SAGE Open Medicine (2021) Vol. 9
Open Access | Times Cited: 94
Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis
Anees Bahji, Paxton Bach, Marlon Danilewitz, et al.
Journal of Addiction Medicine (2022) Vol. 16, Iss. 6, pp. 630-638
Open Access | Times Cited: 45
Anees Bahji, Paxton Bach, Marlon Danilewitz, et al.
Journal of Addiction Medicine (2022) Vol. 16, Iss. 6, pp. 630-638
Open Access | Times Cited: 45
Baclofen for alcohol use disorder
Roberta Agabio, Rosella Saulle, Susanne Rösner, et al.
Cochrane library (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 27
Roberta Agabio, Rosella Saulle, Susanne Rösner, et al.
Cochrane library (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 27
Rising Mortality From Alcohol-Associated Liver Disease in the United States in the 21st Century
Andrew M. Moon, Jeff Y. Yang, A. Sidney Barritt, et al.
The American Journal of Gastroenterology (2019) Vol. 115, Iss. 1, pp. 79-87
Open Access | Times Cited: 68
Andrew M. Moon, Jeff Y. Yang, A. Sidney Barritt, et al.
The American Journal of Gastroenterology (2019) Vol. 115, Iss. 1, pp. 79-87
Open Access | Times Cited: 68
Evidence-Based Pharmacotherapies for Alcohol Use Disorder
Jeremiah Fairbanks, Audrey Umbreit, Bhanu Prakash Kolla, et al.
Mayo Clinic Proceedings (2020) Vol. 95, Iss. 9, pp. 1964-1977
Open Access | Times Cited: 59
Jeremiah Fairbanks, Audrey Umbreit, Bhanu Prakash Kolla, et al.
Mayo Clinic Proceedings (2020) Vol. 95, Iss. 9, pp. 1964-1977
Open Access | Times Cited: 59
Advances in the understanding and management of alcohol-related liver disease
Mark Thursz, Anne Lingford‐Hughes
BMJ (2023), pp. e077090-e077090
Closed Access | Times Cited: 16
Mark Thursz, Anne Lingford‐Hughes
BMJ (2023), pp. e077090-e077090
Closed Access | Times Cited: 16
Baclofen in the treatment of alcohol use disorder: tailored doses matter
Renaud de Beaurepaire, Philippe Jaury
Alcohol and Alcoholism (2024) Vol. 59, Iss. 2
Open Access | Times Cited: 7
Renaud de Beaurepaire, Philippe Jaury
Alcohol and Alcoholism (2024) Vol. 59, Iss. 2
Open Access | Times Cited: 7
A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder
Muhammet Celik, Mark S. Gold, Brian Fuehrlein
Brain Sciences (2024) Vol. 14, Iss. 3, pp. 294-294
Open Access | Times Cited: 7
Muhammet Celik, Mark S. Gold, Brian Fuehrlein
Brain Sciences (2024) Vol. 14, Iss. 3, pp. 294-294
Open Access | Times Cited: 7
Alcohol Use
Joseph H. Donroe, E. Jennifer Edelman
Annals of Internal Medicine (2022) Vol. 175, Iss. 10, pp. ITC145-ITC160
Closed Access | Times Cited: 27
Joseph H. Donroe, E. Jennifer Edelman
Annals of Internal Medicine (2022) Vol. 175, Iss. 10, pp. ITC145-ITC160
Closed Access | Times Cited: 27
Quantifying GABA in Addiction: A Review of Proton Magnetic Resonance Spectroscopy Studies
Claire Shyu, Sofia Chavez, Isabelle Boileau, et al.
Brain Sciences (2022) Vol. 12, Iss. 7, pp. 918-918
Open Access | Times Cited: 23
Claire Shyu, Sofia Chavez, Isabelle Boileau, et al.
Brain Sciences (2022) Vol. 12, Iss. 7, pp. 918-918
Open Access | Times Cited: 23
Medications for the Treatment of Alcohol Dependence—Current State of Knowledge and Future Perspectives from a Public Health Perspective
Iga Stokłosa, Gniewko Więckiewicz, Maciej Stokłosa, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 3, pp. 1870-1870
Open Access | Times Cited: 13
Iga Stokłosa, Gniewko Więckiewicz, Maciej Stokłosa, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 3, pp. 1870-1870
Open Access | Times Cited: 13
New steps for treating alcohol use disorder
Erin J. Campbell, Andrew J. Lawrence, Christina J. Perry
Psychopharmacology (2018) Vol. 235, Iss. 6, pp. 1759-1773
Closed Access | Times Cited: 43
Erin J. Campbell, Andrew J. Lawrence, Christina J. Perry
Psychopharmacology (2018) Vol. 235, Iss. 6, pp. 1759-1773
Closed Access | Times Cited: 43
The influence of anxiety symptoms on clinical outcomes during baclofen treatment of alcohol use disorder: A systematic review and meta-analysis
Roberta Agabio, David S. Baldwin, Hugo Amaro, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 296-313
Open Access | Times Cited: 27
Roberta Agabio, David S. Baldwin, Hugo Amaro, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 296-313
Open Access | Times Cited: 27
Sex differences in neonatal outcomes following prenatal opioid exposure
Nethra K. Madurai, Lauren L. Jantzie, Elizabeth Yen
Frontiers in Pediatrics (2024) Vol. 12
Open Access | Times Cited: 4
Nethra K. Madurai, Lauren L. Jantzie, Elizabeth Yen
Frontiers in Pediatrics (2024) Vol. 12
Open Access | Times Cited: 4
Combined pharmacological and psychosocial interventions for alcohol use disorder
Silvia Minozzi, Giusy Rita Maria La Rosa, Francesco Salis, et al.
Cochrane library (2025) Vol. 2025, Iss. 3
Closed Access
Silvia Minozzi, Giusy Rita Maria La Rosa, Francesco Salis, et al.
Cochrane library (2025) Vol. 2025, Iss. 3
Closed Access
Recent Advances in the Potential of Positive Allosteric Modulators of the GABAB Receptor to Treat Alcohol Use Disorder
Eric Augier
Alcohol and Alcoholism (2021) Vol. 56, Iss. 2, pp. 139-148
Open Access | Times Cited: 24
Eric Augier
Alcohol and Alcoholism (2021) Vol. 56, Iss. 2, pp. 139-148
Open Access | Times Cited: 24
Understanding the genetics and neurobiological pathways behind addiction (Review)
Alexandra Popescu, Maria Marian, Ana Miruna Drăgoi, et al.
Experimental and Therapeutic Medicine (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 24
Alexandra Popescu, Maria Marian, Ana Miruna Drăgoi, et al.
Experimental and Therapeutic Medicine (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 24
Pharmacotherapies and Personalized Medicine for Alcohol Use Disorder: A Review
Falk W. Lohoff
Pharmacogenomics (2020) Vol. 21, Iss. 15, pp. 1117-1138
Open Access | Times Cited: 25
Falk W. Lohoff
Pharmacogenomics (2020) Vol. 21, Iss. 15, pp. 1117-1138
Open Access | Times Cited: 25
The GABAB receptor positive allosteric modulator ASP8062 reduces operant alcohol self-administration in male and female Sprague Dawley rats
Colin N. Haile, Benjamin Carper, Tracy L. Nolen, et al.
Psychopharmacology (2021) Vol. 238, Iss. 9, pp. 2587-2600
Closed Access | Times Cited: 21
Colin N. Haile, Benjamin Carper, Tracy L. Nolen, et al.
Psychopharmacology (2021) Vol. 238, Iss. 9, pp. 2587-2600
Closed Access | Times Cited: 21
Acamprosate may be safer than baclofen for the treatment of alcohol use disorder in patients with cirrhosis: a first description of use in real-world clinical practice
Luke D. Tyson, Alexandra Cheng, Charles Kelleher, et al.
European Journal of Gastroenterology & Hepatology (2021) Vol. 34, Iss. 5, pp. 567-575
Closed Access | Times Cited: 20
Luke D. Tyson, Alexandra Cheng, Charles Kelleher, et al.
European Journal of Gastroenterology & Hepatology (2021) Vol. 34, Iss. 5, pp. 567-575
Closed Access | Times Cited: 20
Repurposing drugs for treatment of alcohol use disorder
Henri‐Jean Aubin
International review of neurobiology (2024), pp. 153-185
Closed Access | Times Cited: 2
Henri‐Jean Aubin
International review of neurobiology (2024), pp. 153-185
Closed Access | Times Cited: 2
Alcohol Use Disorder in Older Adults
Gabriela Fenollal-Maldonado, Derek S. Brown, Heidi L. Hoffman, et al.
Clinics in Geriatric Medicine (2021) Vol. 38, Iss. 1, pp. 1-22
Closed Access | Times Cited: 15
Gabriela Fenollal-Maldonado, Derek S. Brown, Heidi L. Hoffman, et al.
Clinics in Geriatric Medicine (2021) Vol. 38, Iss. 1, pp. 1-22
Closed Access | Times Cited: 15